Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 2,544 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Insomnia, Fibromyalgia
Interventions: Cognitive Behavioral Therapy for Insomnia (CBT-I), Cognitive Behavioral Therapy for Pain (CBT-P); Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Neuronal Ceroid Lipofuscinosis, Batten's Disease
Interventions: Not listed
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: Not listed
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Sleep Apnea, Obstructive
Interventions: Provent; Device
Lead sponsor: St. Luke's Hospital, Chesterfield, Missouri; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Chesterfield, Missouri

Conditions: Cancer, Insomnia
Interventions: CBT-I; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Obesity, Morbid, Postoperative Pain, Postoperative Nausea and Vomiting
Interventions: Gabapentin, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 80 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Obstructive Sleep Apnea
Interventions: Allopurinol; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Narcolepsy, Obstructive Sleep Apnea
Interventions: JZP-110; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 645 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 63
States / cities: Birmingham, Alabama • Glendale, Arizona • Scottsdale, Arizona + 51 more

Conditions: Sleep Disturbances, Depression
Interventions: High Active intervention, Inactive intervention, Mid Level Active Intervention; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 65 Years and older
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: Albany, New York • New York, New York

Conditions: Obstructive Sleep Apnea
Interventions: This is a single arm study, all consented and eligible subjects will be implanted with the Genio® System 2.1; Device
Lead sponsor: Nyxoah Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: Miami, Florida • Summit, New Jersey

Conditions: Transient Insomnia
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 289 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2003
U.S. locations: 12
States / cities: Palm Springs, California • San Diego, California • Miami, Florida + 9 more

Conditions: Obstructive Sleep Apnea
Interventions: Propranolol Oral Tablet, Placebo Oral Tablet; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 20 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstructive Sleep Apnea
Interventions: JZP-110, Placebo oral tablet; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 476 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 45
States / cities: Glendale, Arizona • Scottsdale, Arizona • Little Rock, Arkansas + 38 more

Conditions: Insomnia
Interventions: Daridorexant 10 mg, Daridorexant 25 mg, Daridorexant 50 mg, Placebo; Drug
Lead sponsor: Idorsia Pharmaceuticals Ltd.; Industry
Eligibility: 10 Years to 17 Years
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 12
States / cities: Tucson, Arizona • Little Rock, Arkansas • Brandon, Florida + 8 more

Conditions: Difficult Airway, Obstructive Sleep Apnea
Interventions: Ultrasound; Procedure
Lead sponsor: Vidya Raman; Other
Eligibility: 1 Month to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cancer, Chronic Insomnia
Interventions: cognitive behavioral therapy for insomnia (CBTI), Waitlist control condition; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Obstructive Sleep Apnea
Interventions: PAP therapy, Sham PAP therapy; Device
Lead sponsor: University of Tennessee; Other
Eligibility: 6 Years to 12 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Adrenoleukodystrophy, Restless Legs Syndrome
Interventions: Pramipexole, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia Chronic, Mild Traumatic Brain Injury
Interventions: Sleep Healthy Using the Internet (SHUTi), Education Control Program; Device · Other
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obstructive Sleep Apnea, Hypercapnia, Spinal Cord Injury
Interventions: BiPAP, BiPAP/AVAPS (Phillips Respironics); Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Irritable Bowel Syndrome, Disorders of Gut-brain Interaction
Interventions: Gut-directed Hypnotherapy; Other
Lead sponsor: Children's Hospital at Montefiore; Other
Eligibility: 8 Years to 18 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Mahwah, New Jersey

Conditions: Insomnia, Crohn Disease
Interventions: Behavioral Treatment, Sleep Education Treatment; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Creutzfeldt-Jakob Disease
Interventions: Quinacrine, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obstructive Sleep Apnea, Mild Cognitive Impairment
Interventions: CPAP adherence intervention, Attention control intervention; Behavioral
Lead sponsor: George Mason University; Other
Eligibility: 55 Years to 89 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Abington, Pennsylvania • Philadelphia, Pennsylvania • Fairfax, Virginia

Conditions: Insomnia Disorder
Interventions: Zolpidem; Drug
Lead sponsor: Idorsia Pharmaceuticals Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 5
States / cities: Santa Monica, California • Atlanta, Georgia • Las Vegas, Nevada + 2 more

Search by objective public record fields.

Sleep and Pain Interventions in Fibromyalgia

Neuronal Ceroid Lipofuscinosis and Associated Sleep Abnormalities

Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP

Improving Sleep in Cancer Patients: A Feasibility Trial

Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting

Vascular Pathophysiology in Obstructive Sleep Apnea

"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"

Methodology Issues in a Tailored Light Treatment for Persons With Dementia

Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation

Efficacy of Ramelteon on Transient Insomnia in Healthy Adults

Propranolol for Sleep Apnea Therapy

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Ultrasound to Predict a Pediatric Difficult Airway and Obstructive Sleep Apnea Syndrome in Children

CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients

Effects of Positive Airway Pressure (PAP) in Children With Obstructive Sleep Apnea (OSA)

Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy

Internet-guided Cognitive Behavioral Therapy for Insomnia in Military Service Members With History of TBI

Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury

Audio-recorded Gut-Hypnotherapy for Sleep and Pain in Pediatric Abdominal Pain Disorders

RISE: A Remote Study of Insomnia Treatment in Crohn's Disease

CJD (Creutzfeldt-Jakob Disease) Quinacrine Study

Mild Cognitive Impairment and Obstructive Sleep Apnea

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder